• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS CREA SLIDES; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS CREA SLIDES; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802584
Device Problem Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/20/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that lower than expected vitros crea results were obtained from multiple patient samples from multiple patients using vitros chemistry products crea slides on a vitros 350 chemistry system.The results were lower than expected when compared to an alternate method, siemens dimension, as well as historical results for the patients.The most likely cause of the lower than expected vitros crea patient sample results is an interferent in the samples that affects the vitros crea assay.The patients were taking several medications and vitamins at the time of the event.As vitros crea lot 1536-3508-4450 was a new lot put into use around the time of the event, there were not enough historical quality control (qc) results available to adequately evaluate the performance of the vitros crea reagent.Therefore, an issue related to the performance of the vitros crea reagent could not be ruled out as a contributor of the event.However, continual tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros crea reagent lot 1536-3508-4450.Within run precision testing was not performed on the vitros 350 chemistry system.Performance of the instrument did not change after service actions were performed on the instrument which included cleaning, adjustments and parts replacement.Therefore, an instrument related issue could not be confirmed nor ruled out as a contributor of the event.Additionally, pre-analytical sample processing could not be ruled out as a contributing factor as the customer was not following the sample collection device manufacturer¿s recommended centrifugation protocol.Improper pre-analytical sample handling could have contributed to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.In addition, a method to method difference related issue between the vitros crea assay and the siemens dimension method could not be confirmed nor ruled out as a contributing factor of the event.A definitive assignable cause could not be determined with the information provided.Email address for contact office above is (b)(4).
 
Event Description
A customer obtained lower than expected vitros crea results from multiple patient samples from multiple patients using vitros chemistry products crea slides on a vitros 350 chemistry system when compared to an alternate method, siemens dimension, as well as historical results for the patients.Patient 12 sample 1 vitros crea result of 0.6 mg/dl versus an expected result of 2.43 mg/dl.Patient 12 sample 2 vitros crea result of 1.0 mg/dl versus an expected result of 2.6 mg/dl.Patient 12 sample 3 vitros crea result of 1.5 mg/dl versus an expected result of 2.53 mg/dl.Patient 13 sample 1 vitros crea result of 0.9 mg/dl versus an expected result of 2.16 mg/dl.Patient 13 sample 2 vitros crea result of 1.2 mg/dl versus an expected result of 2.56 mg/dl.Biased results of the magnitude and direction observed may lead to inappropriate physician action if the event were to occur undetected.The lower than expected vitros crea results were reported outside of the laboratory.However, physicians questioned the results, and no treatment was initiated, altered or stopped based on the lower than expected results.There was no allegation of actual patient harm as a result of this event.This report is number three of five mdr¿s for this event.Five 3500a forms are being submitted for this event as five devices were involved.This report corresponds to ortho clinical diagnostics (ortho) inc.Complaint numbers (b)(4) / qerts record id (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS CHEMISTRY PRODUCTS CREA SLIDES
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
513 technology blvd.
rochester NY 14652
Manufacturer Contact
laurie o'riordan
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key11503806
MDR Text Key254832163
Report Number1319809-2021-00018
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 03/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2022
Device Catalogue Number6802584
Device Lot Number1536-3508-4450
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/23/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/04/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-